MRI tests for people with primary sclerosing cholangitis
Part of Digestive system clinical trials.
This study checks whether annual liver scans using MRI (including a special MRI procedure and possibly contrast dye) can help people with primary sclerosing cholangitis. It may improve how the condition is monitored over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary sclerosing cholangitis (PSC) based on accepted medical criteria
- You are 18 years old or older
- You can understand the study and sign consent to take part
- You have not had a liver transplant
- You do not have a known allergy to MRI contrast dye (if they plan to use it)
- You have no implanted device that is unsafe for MRI and you can complete MRI even if you feel claustrophobic
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what drives primary sclerosing cholangitis (PSC) and how it affects the body, using a team approach and medical tests like scans and blood work. It may help researchers understand PSC better and could improve future treatment decisions.
This study follows children and young adults with primary sclerosing cholangitis (PSC) to understand the condition and how it shows up on scans or biopsy. It may help doctors better recognize PSC and choose the best next steps for care.
This study uses MRI scans to find “biomarkers,” or imaging clues, that may help predict how autoimmune liver conditions will progress in children and young adults. If you qualify, you may get MRI imaging to see whether it relates to future health outcomes.
This trial uses MRI scans to look for “biomarkers,” which are measurable signs in the liver, to better understand autoimmune liver diseases in children and teens. It may help doctors track disease and improve care by finding imaging patterns linked to illness.
This study creates a national database for people diagnosed with primary sclerosing cholangitis (PSC). It may help researchers learn more about the condition by collecting health information from participants.
This study collects bile and uses it to grow small lab models (organoids) from people with primary sclerosing cholangitis (PSC) and from people without PSC. Researchers want to better understand how PSC changes bile cells, which could improve future diagnosis or treatments.
Hear when a new Primary Sclerosing Cholangitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.